作者：
Seitaro,Terakura [1]
;
Yoshiko,Atsuta [2]
;
Nobuhiro,Tsukada [3]
;
Takeshi,Kobayashi [4]
;
Masatsugu,Tanaka [5]
;
Junya,Kanda [6]
;
Yuho,Najima [4]
;
Takahiro,Fukuda [7]
;
Naoyuki,Uchida [8]
;
Satoshi,Takahashi [9]
;
Tokiko,Nagamura-Inoue [10]
;
Yasuo,Morishima [11]
;
Koichi,Miyamura [12]
;
Japan Society for Hematopoietic Cell Transplantation
作者单位：
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan. Electronic address: tseit@med.nagoya-u.ac.jp.
[1]
Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan; Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan.
[2]
Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan.
[3]
Division of Hematology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
[4]
Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan.
[5]
Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
[6]
Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
[7]
Department of Hematology, Toranomon Hospital, Tokyo, Japan.
[8]
Division of Molecular Therapy, Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
[9]
Department of Cell Processing and Transfusion, Research Hospital, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
[10]
Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan.
[11]
Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
[12]
DOI
10.1016/j.bbmt.2015.10.006
PMID
26476205
发布时间
2022-03-17
换一批
换一批
